第二届中日泌尿外科学术交流会议日程表

I .开幕式  (14:00 ~ 14:10 )

开幕词: 中日泌尿外科会议 中国代表  北京大学 那 彦群 (Yanqun Na
中日泌尿外科会议 日本代表  岗山大学 公文 裕巳 (Hiromi Kumon

II . 第一部分  (14:10 ~ 15:10 ) (发表时间:7分钟;讨论时间:3分钟)

主持人: 中国・中山大学  黄 健 ( Jian Huang
日本・岗山大学  那须保友 (Yasutomo Nasu
1. Optimum Approach for Prostate Cancer Detection as an Initial Biopsy: A Prospective Randomized Study Comparing Transperineal versus Transrectal Systematic 12-Core Biopsy.
RYOEI HARA, YOSHIMASA JO, TOMOHIRO FUJII, NORIO KONDO, TERUHIKO YOKOYOMA, YOSHIYUKI MIYAJI AND ATSUSHI NAGAI
Kawasaki Medical School, Japan
2. Nadir PSA predicts androgen-independent progression after endocrine therapy in men with metastatic PCA.
Yang Bo, Sun Yinghao
Department of Urology, Changhai Hospital, Shanghai, China
3. Beneficial effects of neoadjuvant hormonal therapy prior to radical prostatectomy in patients with clinically localized prostate cancer.
Jun Qiu1, Yoshihide Higuchi1, Yusuke Yamada1, Yasuo Ueda1, Toru Suzuki1, Takuo Maruyama1, Nobuyuki Kondoh1, Michio Nojima1, Shingo Yamamoto1, Mayumi Shincho2, Seiichi Hirota2, Hiroki Shima1
1. Department of Urology, Hyogo College of Medicine、2. Department of Surgical Pathology, Hyogo College of Medicine, Japan
4. Hormonal therapy combined with surgery in the management of prostate cancer.
Ming Cai, Haige Chen, Wei Xue, Yiran Huang
Department of Urology, Shanghai Renji Hospital, Shanghai, China
5. Prostate cancer mortality and the predictive value of PSA: a prospective cohort study of 231,937 adult male in Taiwan.
Fang-shun Lin and CP Wen
Department of Urology, pathology Mennonite Christian Hospital & Center for health policy Research and Development, National Health Research Institutes  Tai Wan
6. Clinical outcome in patients with locally and locally advanced prostate cancer treated with high-dose-rate brachytherapy.
Yoshimasa Jo, Ryoei Hara, Norio Kondo, Tomohiro Fujii, Teruhiko Yokoyama, Yoshiyuki Miyaji and Atsushi Nagai
Kawasaki Medical School, Japan

III . 第二部分  (15:10 ~ 16:10) (发表时间:7分钟;讨论时间:3分钟)

主持人: 中国・北京大学   张 祥华 (Xianghua Zhang
日本・東海大学  内田 豊昭 (Toyoaki Uchida
7. SALVAGE HIGH-INTENSITY FOCUSED ULTRASOUND IN PATIENTS WITH RECURRENCE AFTER RADIATION THERAPY.
Toyoaki Uchida, Mayura Nakano, Masahiro Nitta, Sunao Shoji, Yoshihiro Nagata.
Tokai University Hachioji Hospital, Japan
8. Clinicopathological study of prostate cancer in Mennonite Christian Hospital: statistical analysis of 97 cases in the past 9 years – preliminary report.
Fang-shu Lin,Yung-chen Tsai,Hui-ming Chung,Fuh-Jinn Luo*
Department of Urology, pathology*, Mennonite Christian Hospital, Taiwan
9. A Clinical study of 290 patients with prostate cancer
Jiaju Lv, Hui Zhang, Haiyang Zhang, Qiang Fu
Provincial Hospital affiliated to Shandong University, China.
10. Natural history of lower urinary tract symptoms after radical retropubic prostatectomy: A comparison with the urination status of elderly women.
Xiu-Xian Wu, Rikiya Taoka, Hiroyuki Tsunemori, Masashi Inui, Mikio Sugimoto, and Yoshiyuki Kakehi
Faculty of Medicine, Kagawa University, Japan
11. The Diagnosis and Surgical Treatment of Primary Bladder Neck Obstruction in Women.
Kexin XU, Guoxi ZHANG, Xiaofeng W ANG
Department of Urology, Peking University People’s Hospital, China
12. Percutaneous Nephrolithotomy in Semisupine Position.
Kewei Xu, Jian Huang
Department of Urology, The Second Affiliated Hospital, Sun Yat-sen University, China

IV. 第三部分 (16:10~16:50) (发表时间:7分钟;讨论时间:3分钟)

主持人: 中国・中国医科大学  毕 建斌 (Jianbin Bi
日本・川崎医科大学  永井 敦 (Atsushi Nagai
13. Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model.
P Huang1, H Kaku1,3,  Watanabe1,2, J Chen1, T Saika1, Y Nasu1,and H Kumon1,2,3
1 Department of Urology, 2 Innovation Center Okayama for Nanobio-Targeted Therapy, 3 Center for Gene and Cell Therapy, Okayama University, Japan.
14. ER stress caused by immunosuppressant is involved in inflammatory reaction-a novel mechanism for immunosuppression?
Shuqi Du, Chuize Kong
Department of Urology, The First Affiliated Hospital, China Medical University,China
15. Aberrant methylation of the tumor suppressor gene DLC1 in the early pathogenic stage of renal cell carcinoma.
Qian Zhang
Department of Urology, Peking University First Hospital, China
16.

The prognostic study of T1G3 bladder cancer and the establishment of prognostic evaluation system.
Xiaoqiang Liu,Guang Sun
Department of Urology, The Second Affiliated Hospital, Tianjin Medical University, China

V.闭幕式  (16:50~17:00)

闭幕词: 中日泌尿外科学会 日方代表 岗山大学  公文 裕巳 (Hiromi Kumon